Search Results 151-160 of 10601 for Latent TB infection

  1. RBX2660 Administered By Colonoscopy For Recurrent Clostridioides Difficile Infection - Mayo Clinic

    The purpose of this study is to explore the safety of RBX2660 when delivered by colonoscopy in subjects with recurrent Clostridioides difficile infection (rCDI) ...

  2. Publications - Richard D. Newcomb, M.D., M.P.H. - Mayo Clinic

    Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel. Clin Infect Dis. 2020 Jul 11; 71 (2):284-290. View PubMed ...

  3. Study Of Determine The Safety And Effectiveness Of SHP647 As Maintenance Therapy In Subjects With Moderate-to-Severe Crohn's Disease - Mayo Clinic

    ... latent or active disease but who are without a generally accepted course of treatment. Subjects with any of the following abnormalities in hematology and/or ...

  4. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    Has active or latent tuberculosis (TB), regardless of treatment history. Has evidence of active Clostridium difficile (C. difficile) infection or is having ...

  5. Microbiota Restoration Therapy For Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Management of recurrent Clostridioides difficile infection and use of fecal microbiota transplantation during the COVID-19 pandemic - Mayo Clinic

    Testing and COVID-19 status matching of both stool donors and fecal microbiota transplantation (FMT) recipients must occur to prevent transmitting COVID-19 ...

  7. Mayo Clinic

    ... disease. We know that Helicobacter pylori infection can cause only peptic ulcer disease but dyspeptic symptoms in some patients and in a small percentage of ...

  8. Infectious Diseases - Clinical trials

    The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. A Study to Evaluate the QuantiFERON-TB ...

  9. Identification Of Chronic Hepatitis B Infections Among African And Asian Immigrants In Minnesota Through Community-Wide Screening - Mayo Clinic

    However, immigrant populations in the US from Asia and sub-Saharan Africa have substantially higher prevalence than the general population and are consequently ...

  10. Bezlotoxumab (MK-6072) Versus Placebo In Children With Clostridium Difficile Infection (CDI) (MK-6072-001) - Mayo Clinic

    ... infection (CDI) who are receiving antibacterial drug treatment. The primary ... Participant eligibility includes age, gender, type and stage of disease, and ...